Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Roche Suspends Dosing in Drug Trials for its GLP-1 Compound, Taspoglutide. See this week’s Item #6.
Newsflash: Roche Suspends Dosing in Drug Trials for its GLP-1 Compound, Taspoglutide
Sep 16, 20101,321 views
Home / KEEP BUT DO NOT DISPLAY / Alerts / Newsflash: Roche Suspends Dosing in Drug Trials for its GLP-1 Compound, Taspoglutide
|
|
|
|